Michael Szarek

机构：St. Michael's Hospital, Mount Sinai Hospital, University of Colorado Anschutz, University of Colorado Denver, Icahn School of Medicine at Mount Sinai · ORCID：0000-0002-0046-0264

发表论文 288 篇 · 总被引 19177 次 · h-index 56

代表论文

• Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk (2025 · New England Journal of Medicine · 被引 97)
• Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients (2025 · Journal of the American College of Cardiology · 被引 34)
• Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial (2025 · The Lancet Diabetes & Endocrinology · 被引 32)
• Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES (2025 · Circulation · 被引 23)
• Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial (2025 · The Lancet · 被引 20)
• Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial (2025 · Journal of the American Heart Association · 被引 17)